We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+18.18%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$4.65B
AUM Growth
+$265M
Cap. Flow
+$90.1M
Cap. Flow %
1.94%
Top 10 Hldgs %
14.76%
Holding
1,541
New
606
Increased
154
Reduced
157
Closed
549

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$22.7M
2
BIIB icon
Biogen
BIIB
+$20.4M
3
NEM icon
Newmont
NEM
+$17.6M
4
CNC icon
Centene
CNC
+$14.6M
5
W icon
Wayfair
W
+$14.5M

Sector Composition

Rank Sector Weight
1 Healthcare 5.25%
2 Consumer Discretionary 3.98%
3 Technology 1.67%
4 Materials 1.07%
5 Industrials 1.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTAI icon
651
CALL
FTAI Aviation
FTAI
$21.1B
$1.16M 0.02%
48,011
+42,156
+720% +$943K
IGMS
652
CALL
DELISTED
IGM Biosciences
IGMS
$1.15M 0.02%
+15,000
New +$1.37M
IGMS
653
PUT
DELISTED
IGM Biosciences
IGMS
$1.15M 0.02%
+15,000
New +$1.37M
SNOW icon
654
Snowflake
SNOW
$102B
$1.15M 0.02%
+5,000
New +$1.33M
MSFT icon
655
Microsoft
MSFT
$3.45T
$1.13M 0.02%
4,810
MCRB icon
656
CALL
Seres Therapeutics
MCRB
$46.8M
$1.13M 0.02%
+2,740
New +$1.26M
ASO icon
657
Academy Sports + Outdoors
ASO
$2.94B
$1.12M 0.02%
+41,656
New +$996K
SAGE
658
PUT
DELISTED
Sage Therapeutics
SAGE
$1.12M 0.02%
+15,000
New +$1.23M
DCPH
659
CALL
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$1.12M 0.02%
25,000
-10,000
-29% -$466K
DCPH
660
PUT
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$1.12M 0.02%
25,000
-10,000
-29% -$466K
GPRE icon
661
Green Plains
GPRE
$1.18B
$1.12M 0.02%
+41,400
New +$948K
KNSA icon
662
CALL
Kiniksa Pharmaceuticals
KNSA
$5.8B
$1.11M 0.02%
60,000
+30,000
+100% +$614K
KNSA icon
663
PUT
Kiniksa Pharmaceuticals
KNSA
$5.8B
$1.11M 0.02%
60,000
+30,000
+100% +$614K
FLR icon
664
Fluor
FLR
$7.01B
$1.08M 0.02%
+47,000
New +$913K
MGI
665
CALL
DELISTED
MoneyGram International, Inc. New
MGI
$1.08M 0.02%
+164,400
New +$1.2M
MP icon
666
CALL
MP Materials
MP
$7.36B
$1.08M 0.02%
+30,000
New +$1.11M
SPT icon
667
Sprout Social
SPT
$516M
$1.07M 0.02%
+18,500
New +$1.16M
META icon
668
Meta Platforms (Facebook)
META
$1.42T
$1.06M 0.02%
+3,600
New +$969K
ALLO icon
669
CALL
Allogene Therapeutics
ALLO
$649M
$1.06M 0.02%
+30,000
New +$1.01M
ALLO icon
670
PUT
Allogene Therapeutics
ALLO
$649M
$1.06M 0.02%
+30,000
New +$1.01M
VALE icon
671
Vale
VALE
$64.1B
$1.05M 0.02%
60,700
+1,500
+3% +$26.2K
PR
672
PUT
Permian Resources
PR
$17.8B
$1.05M 0.02%
+250,000
New +$877K
GAP
673
CALL
The Gap Inc
GAP
$7.23B
$1.04M 0.02%
35,000
-55,000
-61% -$1.37M
GAP
674
PUT
The Gap Inc
GAP
$7.23B
$1.04M 0.02%
+35,000
New +$870K
ARNA
675
CALL
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.04M 0.02%
15,000
-15,100
-50% -$1.16M

Similar funds

Caption Management's Q1 2021 Portfolio in Review

As of Q1 2021, Caption Management held 1,541 positions worth $4.65B, up 6% from $4.39B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Caption Management's Q1 2021 filing shows 606 new, 154 increased, 157 reduced and 549 closed positions. Its largest new stake was Amgen: 95,000 shares worth $23.6M. The largest sale was Enphase Energy, an estimated $25.5M.

By sector, the portfolio is most concentrated in Healthcare at 5.2% of assets, up from 3.2% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Caption Management's largest Q1 2021 buy was Amgen: 95,000 shares worth $23.6M.
  • Caption Management added most to Wayfair in Q1 2021, an estimated $14.5M increase.
  • Caption Management's biggest Q1 2021 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $19.6M.
  • Caption Management fully exited Enphase Energy in Q1 2021, selling an estimated $25.5M.
  • Caption Management's ten largest holdings make up 15% of its $4.65B portfolio in Q1 2021.
  • Caption Management opened 606 new positions and closed 549 in Q1 2021.
  • Caption Management's portfolio value rose 6% quarter-over-quarter to $4.65B.

Based on Caption Management's 13F filing for Q1 2021, filed 17 May 2021.